fidelma fitzpatrick consultant microbiologist, health protection surveillance centre &

57
Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre & Beaumont Hospital, Dublin, Ireland HPSC, SARI and National HCAI surveillance

Upload: shandi

Post on 08-Jan-2016

29 views

Category:

Documents


0 download

DESCRIPTION

HPSC, SARI and National HCAI surveillance. Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre & Beaumont Hospital, Dublin, Ireland. What is HPSC? What is SARI? National HCAI surveillance What about line infections?. H.P.S.C. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Fidelma Fitzpatrick

Consultant Microbiologist,Health Protection Surveillance Centre &

Beaumont Hospital, Dublin, Ireland

HPSC, SARI and National HCAI surveillance

Page 2: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

1. What is HPSC?

2. What is SARI?

3. National HCAI surveillance

4. What about line infections?

Page 3: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

H.P.S.C.

Health Protection Surveillance Centre

Page 4: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

4

HPSC- History and Governance

• Established (NDSC) Nov 1998– Surveillance of Communicable Diseases– Epidemiological investigation, Advice, Training and

Research– International Liaison EU/WHO

• Incorporated into HSE in January 2005– Division of Population Health;– Name change - Health Protection Surveillance Centre– Same remit

Page 5: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

5

HPSC ActivitySurveillance

Provision of

Expert Advice

Research

Training

• Collecting data• Collating it• Analysing it and• Communicating information to those who need to know

• Operational Support to the Health System• Policy advice • Public information

• Identifying and developing best practice – initiation and collaboration

• For professionals in communicable disease control – especially joint training• Teaching

Page 6: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

6

CEO

Office of the CEO

Communication, Service

Governance

Director of HR

Assistant Directors x 3

Industrial Relations, Employee Wellbeing

& Welfare, Legal/Advisory

Services, Partnership,

Workforce Planning, Recruitment, Employment Monitoring,

Performance Management,

Learning & Development, Management Development,

PPARS

Director of Population Health

Assistant Directors x 4

Strategic Planning & Evaluation, Health Intelligence, Health Inequality & Social Inclusion, Health

Promotion & Improvement,

Communicable Diseases

Surveillance & Control & Other

Health Protection Issues

Director of PCCC

Assistant Directors x 4

Planning, Monitoring & Evaluation,Contracting

Development of Service Frameworks,Provision of Expert

Advice, System Support

Director of Shared Services

Assistant Directors x 2

GMS PB,

HR – Payroll, Superannuation,

Recruitment. Personnel,

Finance – Purchase to Pay, Financial

Reporting, Accounting

Receivables, Financial Systems &

Reporting, ICT – Infrastructure

Services,Application Services,

Data & Integration Service,

ICT Customer Support, Customer Relations, Service

Development

Director of NHO

Assistant Directors x 4

Planning,Contracts &

Utilisation Review,Quality Risk &

Customer Care,National Ambulance

Service

Director of Finance

Assistant Directors x 4

Financial Planning, Costing &

Evaluation, Statutory Reporting & Control,

Management Reporting,

Procurement & VFM, FISP

Director of CMOD

Assistant Directors x 2

Change Management,

Central Resource, Leadership,

Development, Streamlining

Agencies – Change Process, Service Improvement & Organisational Development,

Director of ICT

Assistant Directors x 4

Design &

Procurement, Implementation &

Rollout, Project Governance & interconnectivity,

Projects Management,

Strategy Formulation, Library

& Research, Innovation Centre

Director of Corporate Afffairs

Where HPSC fits into the Great Scheme of Things

HPSC

Page 7: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

www.hpsc.ie

Page 8: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

www.hpsc.ie

Page 9: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 10: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

C. difficile

Page 11: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 12: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 13: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 14: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 15: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 16: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

MRSA

Page 17: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 18: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

…….and more!

Page 19: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

2001

Page 20: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 21: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

http://www.hse.ie/eng/Publications/Health_Protection/Health_Care_Associated_Infection/Governance_Framework_March_2007.pdf

Page 22: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

National guidelines

Page 23: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

•National committee•Subcommittees

• Surgical site infection surveillance• Catheter-associated UTI• IV catheter-associated infection•Antibiotic stewardship (x2)•MRSA in ICU

•Regional committees

Page 24: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

1. EARSS

2. ESAC

3. MRSA in ICU Prevalance Survey

4. Alcohol hand gel consumption

5. North South MRSA Study 1999

6. HIS HCAI Prevalance Study 2006

Page 25: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 26: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

www.hpsc.ie

Page 27: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 28: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 29: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 30: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 31: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 32: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 33: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 34: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 35: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

MRSA in ICU Prevalance Study

Page 36: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 37: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

• 32 hospital ICU’s in 2008

• Average MRSA prevalence rates 2.9% to 21.2%

• MRSA acquisition rates vary nationally from 0% to 3.3%.

• Data suggests that ICU’s with lower isolation room resources have a higher MRSA acquisition rate compared to ICU’s with more resources despite having a similar percentage of patients ventilated.

Page 38: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

MRSA IsolatesMRSA Isolates

192 cases in North (5.3/100,000)

508 cases in South (6.5/100,000)

Males > FemalesMales > Females

Highest rates, 65 years or more

25-44 yrs. 4.4/100,000 (South)

75yrs. 111/100,000 (South)

Page 39: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

SouthSouthNorthNorth

Hospital 92% 69%

GP 4% 20%

Nursing Home 2% 10%

Psychiatry 2% 1%

Page 40: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Clinical Status Clinical Status No. (%)No. (%)

Colonised (carriage) 271(62)

Local infection 124(28)

Invasive infection 44(10)

Risk factors for invasive diseaseRisk factors for invasive disease

–iv line– surgery/ invasive procedure

Page 41: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

NorthNorth SouthSouth

MRSA/S aureus bacteraemia 25% 36%

Hospitals with antibiotic policy 95% 41%

Infection control nurse on site 100% 85%

Isolation rooms available 100% 87%

Page 42: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

HIS HCAI Prevalance Survey

Page 43: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Prevalence Rate of HCAI and MRSA

8.19

1.28

6.35

0.87

5.43

0.85

4.89

0.49

0

1

2

3

4

5

6

7

8

9

HCAI Prevalence Rate MRSA Prevalence Rate

Rate

(%)

England Wales N. Ireland Rep of Ireland

Page 44: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Prevalence Rate of HCAI and MRSA by Infection Type (1)

0

1

2

3

4

5

6

BSI UTI Pneumonia SSI BSI UTI Pneumonia SSI

Rate

(%)

England Wales N. Ireland Rep of Ireland

Page 45: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Prevalence of HCAI by Infection type (2)

0

0.5

1

1.5

2

2.5

Bone & joint Cardiovascular System Central Nervous System Eyes,ENT or Mouth GI system LRT (excl pneumonia) Reproductive tract Skin & soft tissue Systemic

Rate

(%)

England Wales N. Ireland Rep of Ireland

Page 46: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 47: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 48: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &
Page 49: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Clostridium difficile Prevalence Rate

1.98

1.1 1.13

0.48

0.19

0

0.5

1

1.5

2

England Wales N. Ireland Rep of Ireland BH

%

Page 50: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

North South MRSA Study

• 5% (North) and 10% (South) cases had invasive infection

• Patients with invasive infection were more likely to have a history of PVC or CVC than those with colonisation only.

Page 51: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

HIS HCAI Prevalance Survey

• 449 patients had a primary BSI, 184(41%) of which were CVC related

• CVC presence significantly associated with primary BSI

• More patients in RoI had IVCs in situ when compared N. Irl

• As in other countries, presence of a CVC in Irish patients was associated with a HCAI.

Page 52: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

S.aureus bacteraemia:283 cases

South-East Ireland 2002-6

Source Number % of Total

Central Venous Catheter 91 32%

Peripheral Venous Catheter 42 15%

Burns et al .CMI 2007 13;(s1)s520

47% due tovenous access

Page 53: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Enhanced EARSS

2175

587

98

One in four S.aureus bacteraemias in Ireland is due to infectionassociated with a central venous catheter

One in twenty S.aureus bacteraemias in Ireland is due to infectionassociated with a peripheral venous cannula

Page 54: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Enhanced EARSS

2175

587

98

One in four S.aureus bacteraemias in Ireland is due to infectionassociated with a central venous catheter

One in twenty S.aureus bacteraemias in Ireland is due to infectionassociated with a peripheral venous cannula

Page 55: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Enhanced EARSS

Page 56: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Irish guidelines: Prevention of CR-BSI

Page 57: Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre &

Summary

• IV lines = potentially modifiable risk factor for bacteraemia

• Surveillance data essential to monitor effectiveness of any intervention

• ‘You cant manage what you cant measure’